Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 357

1.

Socio-demographic and Adherence Factors Associated with Viral Load Suppression in HIV-infected Adults initiating therapy in Northern Nigeria: a Randomized Controlled Trial of a Peer Support Intervention.

Coker M, Etiebet MA, Chang H, Awwal G, Jumare J, Babashani M, Habib AG, Dakum P, Charurat ME, Abimiku A, Blattner WA, Eng M, Ndembi N.

Curr HIV Res. 2015 Apr 7. [Epub ahead of print]

PMID:
25845393
2.

Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid among Clinical Mycobacteria Isolates in Ilorin, Nigeria.

Nwofor AC, Nyamngee A, Nwabuisi C, Iwakun M, Gidado M, Mensah C, Dakum P, Agbede OO, Ndembi N, Blattner W, Abimiku A.

Curr HIV Res. 2015 Apr 7. [Epub ahead of print]

PMID:
25845392
3.

HIV-1 Antiretroviral Drug Resistance in Pregnant Women in Jamaica: A Preliminary Report.

Amarakoon II, Ramkissoon A, Pierre R, Eysaguirre LM, Carr JK, Blattner WA, Roye ME.

West Indian Med J. 2014 Aug 21;63(6). doi: 10.7727/wimj.2014.016. [Epub ahead of print]

PMID:
25803373
4.

Correlates of Patient Retention in HIV Care and Treatment Programs in Nigeria.

Ugoji C, Okere N, Dakum P, Ake-Uzoigwe R, Igboelina D, Ndembi N, Ekong E, Charurat M, Blattner W.

Curr HIV Res. 2015 Mar 17. [Epub ahead of print]

PMID:
25777516
5.

Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria.

Charurat ME, Emmanuel B, Akolo C, Keshinro B, Nowak RG, Kennedy S, Orazulike I, Ake J, Njoku O, Baral S, Blattner W; TRUST Study Group.

J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S114-23. doi: 10.1097/QAI.0000000000000439.

PMID:
25723975
6.

Evaluating respondent-driven sampling as an implementation tool for universal coverage of antiretroviral studies among men who have sex with men living with HIV.

Baral SD, Ketende S, Schwartz S, Orazulike I, Ugoh K, Peel SA, Ake J, Blattner W, Charurat M.

J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S107-13. doi: 10.1097/QAI.0000000000000438.

PMID:
25723974
7.

Adherence to Anti-Retroviral Therapy in North Central Nigeria.

Avong YK, Wyk BV, Njab J, Abimiku AG, Ndembi N, Okuma J, Ogbanufe O, Ekong E, Dakum P, Blattner W.

Curr HIV Res. 2015 Feb 1. [Epub ahead of print]

PMID:
25642849
8.

Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria.

Aliyu G, El-Kamary SS, Abimiku A, Hungerford L, Obasanya J, Blattner W.

BMC Infect Dis. 2014 Dec 13;14:675. doi: 10.1186/s12879-014-0675-0.

9.

Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants.

Frey SE, Peiperl L, McElrath MJ, Kalams S, Goepfert PA, Keefer MC, Baden LR, Lally MA, Mayer K, Blattner WA, Harro CD, Hammer SM, Gorse GJ, Hural J, Tomaras GD, Levy Y, Gilbert P, deCamp A, Russell ND, Elizaga M, Allen M, Corey L.

Clin Vaccine Immunol. 2014 Nov;21(11):1589-99. doi: 10.1128/CVI.00450-14. Epub 2014 Sep 24.

10.

Screening test for HTLV-III (AIDS agent) antibodies: specificity, sensitivity, and applications.

Weiss SH, Goedert JJ, Sarngadharan MG, Bodner AJ; AIDS Seroepidemiology Collaborative Working Group, Gallo RC, Blattner WA.

JAMA. 2014 Jul 23-30;312(4):442. doi: 10.1001/jama.2013.279636. No abstract available.

PMID:
25038372
11.

Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria.

Akolo C, Royal W 3rd, Cherner M, Okwuasaba K, Eyzaguirre L, Adebiyi R, Umlauf A, Hendrix T, Johnson J, Abimiku A, Blattner WA.

J Neurovirol. 2014 Aug;20(4):380-7. doi: 10.1007/s13365-014-0254-6. Epub 2014 Jun 14.

PMID:
24927825
12.

Comparison of HIV oral fluid and plasma antibody results during early infection in a longitudinal Nigerian cohort.

Luo W, Masciotra S, Delaney KP, Charurat M, Croxton T, Constantine N, Blattner W, Wesolowski L, Owen SM.

J Clin Virol. 2013 Dec;58 Suppl 1:e113-8. doi: 10.1016/j.jcv.2013.08.017.

PMID:
24342470
13.

Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria.

Aliyu G, El-Kamary SS, Abimiku A, Ezati N, Mosunmola I, Hungerford L, Brown C, Tracy KJ, Obasanya J, Blattner W.

Tuberc Res Treat. 2013;2013:650561. doi: 10.1155/2013/650561. Epub 2013 Jul 16.

14.

Elevated hypermutation levels in HIV-1 natural viral suppressors.

Eyzaguirre LM, Charurat M, Redfield RR, Blattner WA, Carr JK, Sajadi MM.

Virology. 2013 Sep 1;443(2):306-12. doi: 10.1016/j.virol.2013.05.019. Epub 2013 Jun 19.

15.

Cervical cancer risk factors among HIV-infected Nigerian women.

Ononogbu U, Almujtaba M, Modibbo F, Lawal I, Offiong R, Olaniyan O, Dakum P, Spiegelman D, Blattner W, Adebamowo C.

BMC Public Health. 2013 Jun 14;13:582. doi: 10.1186/1471-2458-13-582.

16.

Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria.

Aliyu G, El-Kamary SS, Abimiku A, Brown C, Tracy K, Hungerford L, Blattner W.

PLoS One. 2013 May 9;8(5):e63170. doi: 10.1371/journal.pone.0063170. Print 2013.

17.

Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria.

Anude CJ, Eze E, Onyegbutulem HC, Charurat M, Etiebet MA, Ajayi S, Dakum P, Akinwande O, Beyrer C, Abimiku A, Blattner W.

BMC Infect Dis. 2013 Mar 1;13:113. doi: 10.1186/1471-2334-13-113.

18.

Immunologic outcomes of antiretroviral therapy among HIV-infected Nigerian children and its association with early infant feeding and nutritional status at treatment initiation.

Omoni AO, Christian PS, Sadoh WE, Okechukwu A, Olateju E, Omoigberale A, Blattner W, Charurat ME.

Pediatr Infect Dis J. 2013 Jul;32(7):e291-7. doi: 10.1097/INF.0b013e31828b2a2f.

PMID:
23411626
19.

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.

Yates NL, Stacey AR, Nolen TL, Vandergrift NA, Moody MA, Montefiori DC, Weinhold KJ, Blattner WA, Borrow P, Shattock R, Cohen MS, Haynes BF, Tomaras GD.

Mucosal Immunol. 2013 Jul;6(4):692-703. doi: 10.1038/mi.2012.107. Epub 2013 Jan 9.

20.

Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy.

Etiebet MA, Shepherd J, Nowak RG, Charurat M, Chang H, Ajayi S, Elegba O, Ndembi N, Abimiku A, Carr JK, Eyzaguirre LM, Blattner WA.

AIDS. 2013 Feb 20;27(4):553-61. doi: 10.1097/QAD.0b013e32835b0f59.

PMID:
23079810
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk